Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:5HW's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 14.3
vs FRA:5HW: 19.79
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Elegance Optical International Holdings (FRA:5HW) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elegance Optical International Holdings's PE Ratio (TTM) for today is calculated as:
Elegance Optical International Holdings's share price for today is €0.001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elegance Optical International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elegance Optical International Holdings EV-to-EBITDA Chart
Elegance Optical International Holdings Annual Data
FRA:5HW vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Elegance Optical International Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elegance Optical International Holdings EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elegance Optical International Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Elegance Optical International Holdings's EV-to-EBITDA falls into.
Elegance Optical International Holdings's current Enterprise Value is €15.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elegance Optical International Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €0.80 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elegance Optical International Holdings (FRA:5HW) has a EV-to-EBITDA of 19.85 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Elegance Optical International Holdings.
Is Elegance Optical International Holdings' EV-to-EBITDA too high?
Elegance Optical International Holdings' current EV-to-EBITDA is 19.85. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.30. Elegance Optical International Holdings' value of 19.85 is 38.8% above this industry median. Overall, Elegance Optical International Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Elegance Optical International Holdings' EV-to-EBITDA compare to ISRG and BDX?
Elegance Optical International Holdings' EV-to-EBITDA of 19.85 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.30. Elegance Optical International Holdings' value of 19.85 is 38.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.30, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elegance Optical International Holdings's current EV-to-EBITDA of 19.85 is 38.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Elegance Optical International Holdings. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elegance Optical International Holdings's current EV-to-EBITDA is 19.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elegance Optical International Holdings stock overvalued right now?
Elegance Optical International Holdings (FRA:5HW) has a current EV-to-EBITDA of 19.85. The current EV-to-EBITDA is 19.85 and 38.8% above the Medical Devices & Instruments industry median of 14.30. Elegance Optical International Holdings' overall GF Score™ is 8/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Elegance Optical International Holdings (FRA:5HW), the current EV-to-EBITDA is 19.85 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Elegance Optical International Holdings Ltd and its subsidiaries are the manufacturers and sellers of optical frames and sunglasses. Its operating segments include the trading segment engaged in the manufacture and trading of optical frames and sunglasses; the Property investment segment is involved in leasing properties for rental income; the Debts and securities investment segment engaged in investments in financial instruments and quoted shares; Film investment and distribution segment engaged in film right and movie distributions; and Energy business. It derives key revenue from the trading segment. It operates in Europe, America, the PRC (including Hong Kong), and other countries.
8GF Score
Get the complete analysis for FRA:5HW
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5HW has been successfully added to your 
